Impromen (Bromperidol)

Bromperidol works by blocking dopamine D2 receptors in the brain, decreasing dopaminergic neurotransmission that contributes to psychotic symptoms. It also antagonizes certain serotonin receptors, which may enhance its antipsychotic effect and influence mood and motor pathways.

The dosage of Impromen is individualized. A qualified prescriber determines the appropriate dose based on the patient’s clinical condition, response to therapy, and any relevant medical factors. Dosing information is provided in the prescribing information.

Safety data for bromperidol in pregnancy and lactation are limited. The drug should be used only if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To request Impromen, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After verification of trade or institutional credentials, the sales team will provide pricing, availability, shipping details, and any necessary import documentation.

Impromen (bromperidol) belongs to the butyrophenone class, similar to haloperidol. Compared with haloperidol, bromperidol may have a broader receptor profile, affecting both dopamine and serotonin receptors, which can influence efficacy and side‑effect patterns. Choice of therapy depends on individual patient response and tolerability.

Impromen should be stored at room temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.

Impromen is administered orally. The tablet should be swallowed whole with water and can be taken with or without food, unless the prescribing information advises otherwise. Patients should follow the dosing schedule prescribed by their clinician.

The most serious risks include neuroleptic malignant syndrome, a potentially fatal reaction characterized by fever, muscle rigidity, and autonomic instability; tardive dyskinesia, which may be irreversible; severe hypotension; and cardiac arrhythmias such as QT prolongation. Immediate medical attention is required if these events occur.

Impromen should not be used by individuals with known hypersensitivity to bromperidol or any component of the formulation. It is also contraindicated in patients with severe central nervous system depression, uncontrolled cardiovascular disease, or a history of neuroleptic malignant syndrome.